View Clinical Trial (Medical Research Study)
Medical Oncology Care in the NCI, Center for Cancer Research
| City: |
|
Bethesda |
| State: |
|
Maryland |
| Zip Code: |
|
20892 |
| Conditions: |
|
Unspecified Adult Solid Tumor, Protocol Specific |
| Purpose: |
|
RATIONALE: Collecting and storing samples of tumor tissue, blood, urine, and cerebrospinal
fluid from patients to test in the laboratory may help the study of cancer.
PURPOSE: This study is collecting and storing tissue and fluid samples from patients
receiving standard care at the National Cancer Institute.
|
| Study Summary: |
|
OBJECTIVES:
- Collect and store biological samples from patients at the National Cancer Institute not
currently enrolled in an active research study while providing standard care treatment
and medical follow up.
OUTLINE: Biological samples, including tumor tissue, surgical tissue, blood, urine, and
cerebrospinal fluid are collected during usual care and stored.
PROJECTED ACCRUAL: A total of 1,000 patients will be accrued for this study.
|
| Criteria: |
|
DISEASE CHARACTERISTICS:
- Meets 1 of the following criteria:
- Enrolled in a Center for Cancer Research (CCR) nontreatment research study and
requires standard of care therapy
- Eligible for a CCR research study in the near future but requires cancer therapy
prior to enrollment
- Standard of care therapy is requested through the Medical Oncology Clinical
Research Unit (MOCRU) consult service
- Treatment of cancer or risk of cancer would add significant value to the Medical
Oncology fellowship training program
- Previously enrolled in National Cancer Institute (NCI) trials in which important
scientific endpoints, including natural history of the disease and late
toxicities, were collected
- Medical welfare could be seriously compromised by referral back to the
community, such as rare or complex disease where community treatment is
inadequate or adequate community resources are unavailable
- Received majority of prior specialized medical care on research protocols at CCR
and approaching the end of the natural history of disease
- Diagnosed with cancer or HIV, or at risk for cancer or HIV, and cancer treatment
or management at the NCI is requested via the MOCRU
- CCR investigator decides it is in the best interest of the patient and NCI for
patient to be enrolled on protocol and continue to receive care and follow up
within the MOCRU
PATIENT CHARACTERISTICS:
- Not specified
PRIOR CONCURRENT THERAPY:
- Not specified
|
| NCT ID: |
|
NCT00898625 |
| Primary Contact: |
|
Principal Investigator Giuseppe Giaccone, MD, PhD NCI - Medical Oncology Branch
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Bethesda, Maryland 20892 United States
Clinical Trials Office - Warren Grant Magnusen Clinical Center Phone: 888-NCI-1937
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 25, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|